Norepinephrine

vasoactive intestinal peptide ; Rattus norvegicus







22 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33220286 Administration of a VIP-antagonist in vivo modifies ovarian hormone secretion in a rat model with polycystic ovary syndrome. 2021 Jan 15 1
2 19936638 The effects of vasoactive intestinal peptide on dura mater nitric oxide levels and vessel-contraction responses in sympathectomized rats. 2010 Jun 1
3 20150881 Norepinephrine modulates the effect of neuropeptides in coeliac ganglion on ovarian hormones release: its relationship with ovarian nitric oxide and nerve growth factor. 2010 1
4 15567974 In vitro effect of neuropeptides on ovary or celiac ganglion affects the release of progesterone from ovaries in the rat. 2004 Dec 2
5 11931349 Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide-stimulated cyclic AMP synthesis in rat cerebral cortical slices: interaction with noradrenaline, adrenaline, and forskolin. 2002 Feb-Apr 2
6 10194528 Actions of vasoactive intestinal peptide on the rat adrenal zona glomerulosa. 1999 Apr 1
7 9510417 Ultrastructural evidence for combined action of noradrenaline and vasoactive intestinal polypeptide upon neurons, astrocytes, and blood vessels of the rat cerebral cortex. 1998 1
8 9798735 Adrenergic and peptidergic control of the regulation of cAMP efflux and melatonin secretion from perifused rat pineal gland. 1998 Aug 1
9 7830053 Cyclic AMP-dependent modulation of vesicular monoamine transport in pheochromocytoma cells. 1995 Feb 2
10 7896056 Effects of vasoactive intestinal peptide and its homologues on the noradrenaline-mediated secretion of fluid and protein from the rat submandibular gland. 1994 Nov 3
11 8006835 Differential secretion of catecholamines in response to peptidergic and cholinergic transmitters in rat adrenals. 1994 Mar 15 3
12 8190350 Neuropeptide Y (NPY)- and vasoactive intestinal peptide (VIP)-induced aldosterone secretion by rat capsule/glomerular zone could be mediated by catecholamines via beta 1 adrenergic receptors. 1994 Jan 17 1
13 1864314 Mechanism for the cardiovascular action of intracerebroventricularly administered vasoactive intestinal polypeptide in rats. 1991 Mar 1
14 2852216 Peptidergic and adrenergic regulation of the intracellular 3',5'-cyclic adenosine monophosphate content in cultured rat Schwann cells. 1988 Dec 1
15 20501252 Vasoactive intestinal polypeptide excitation of cerebral cortical neurons: lack of synergism with adenosine and noradrenaline. 1988 2
16 2863199 Adrenergic effects on secretion of epidermal growth factor from Brunner's glands. 1985 Sep 3
17 3866254 Vasoactive intestinal polypeptide acts synergistically with norepinephrine to depress spontaneous discharge rate in cerebral cortical neurons. 1985 Dec 1
18 6089134 Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology. 1984 Mar-Apr 1
19 6473156 Angiotensin II and norepinephrine antagonize the secretory effect of VIP in rat ileum and colon. 1984 Mar-Apr 3
20 6195528 Neuropeptides modulate the beta-adrenergic response of purified astrocytes in vitro. 1983 Oct 20-26 1
21 6106694 Vasoactive intestinal polypeptide (VIP)-sensitive adenylate cyclase in rat brain: regional distribution and localization on hypothalamic neurons. 1980 Aug 1
22 222624 Localization and possible function of peptidergic neurons and their interactions with central catecholamine neurons, and the central actions of gut hormones. 1979 Aug 1